Bayer Shares Jump After Results Beat Expectations on Pharma Strength
In This Article:
Bayer shares jumped after the company reported better-than-expected sales and adjusted earnings for the first quarter, with cost-cutting and demand for kidney and cancer drugs boosting its pharmaceutical business.
Terms and Privacy Policy